Evidence map

ReviewFrontiers in immunology2026

NAD(H)-dependent corepressor CTBP1 integrates metabolic signals to drive oncogenic programs.

Enes Yağız Akdaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41972124